Andrew “Andy” Pasternak

 

Andy Pasternak is a partner in Bain & Company's Chicago office. He is Bain’s Healthcare Practice Leader for the Americas, and is also a member of the M&A Practice.  

 

Mr. Pasternak has nearly 20 years of management consulting experience in the healthcare sector, advising large pharmaceutical companies, medical technology companies, biotechnology firms, private investment funds, NGOs and government agencies. He holds deep expertise in growth strategy, market entry, competitive strategy, M&A, organizational design, operational strategy and performance improvement.

In the pharmaceutical space, Mr. Pasternak has worked across a wide range of specialty Therapeutic Areas (including rare diseases) and Functions, including Commercial, Operations, and R&D. In addition, he is an internationally recognized strategy consultant in the areas of vaccines and infectious diseases.

Finally, Mr. Pasternak is one of Bain’s leading experts on complex M&A transactions, in particular large corporate separations / spin-offs, divestitures and integrations of carve-outs. His experience in this area is wide-ranging across strategic, organizational, operational and transactional issues.

Prior to joining Bain in 2008, Mr. Pasternak was a founding partner in the Health & Life Sciences Practice at Oliver Wyman, a global management consultancy. He also worked in the Corporate Finance Group of J.P. Morgan Securities.

Mr. Pasternak earned an M.B.A. from the University of Chicago Graduate School of Business and a B.A. in Economics from Northwestern University.